Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.
D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D006333:Heart Failure / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000502:physiology; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use; D051193:Toll-Like Receptors / Q000187:drug effects / Q000502:physiology*
D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors; D051193:Toll-Like Receptors